共 35 条
- [22] Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma [J]. npj Primary Care Respiratory Medicine, 32
- [30] Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2023, 16 (10):